BIO MANUFACTURING OTHERS

Brand Owner (click to sort) Address Description
NEOTIL Ludwig Institute for Cancer Research Ltd. Stadelhoferstrasse 22 Zürich 8001 Switzerland bio-manufacturing for others;Pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for use in immunology and oncology; personalized cell therapies for the treatment of cancer; biological preparations for the identification and treatment of cancer and oncological conditions; cell therapies and treatments containing cells, and lymphocytes for medical and clinical use; cells for scientific, laboratory or medical research;Providing medical services in the nature of adoptive cell therapy; laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, biological and biotechnological substances and biomanufacturing; development and production of pharmaceuticals; research and development of pharmaceuticals and pharmaceutical treatments; biotechnological analysis and research services;
PACT PACT Pharma, Inc. 2 Corporate Drive South San Francisco CA 94080 Bio-manufacturing for others, namely, manufacturing of adoptive cell and personalized adoptive cell therapies; none of the foregoing for use in connection with patient self-management, pain management or substance misuse;
PACT PACT Pharma, Inc. 2 Corporate Drive South San Francisco CA 94080 Bio-manufacturing for others, namely, manufacturing of adoptive cell and personalized adoptive cell therapies; none of the foregoing for use in connection with patient self-management, pain management or substance misuse;The mark consists of the word PACT having the letter T split vertically.;Color is not claimed as a feature of the mark.;
PACT PACT Pharma, Inc. 2 Corporate Drive South San Francisco CA 94080 Bio-manufacturing for others, namely, manufacturing of adoptive cell and personalized adoptive cell therapies; none of the foregoing for use in connection with patient self-management, pain management or substance misuse;The mark consists of the stylized wording PACT in the color white with a line split between the letter T on a background that is an irregular circular shape and 3 colors. The first color closest to the word PACT is dark blue, the center color is light blue, and the last color is green.;pharmaceutical preparations and substances for the treatment of genetic diseases, immunological diseases and cancer; personalized cell therapies for medical use for the treatment of cancer; biological preparations for medical purposes, namely, in the field of personalized cell therapies for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; pharmaceuticals, namely, immunotherapies for the treatment of cancer; oncological preparations, namely, pharmaceutical products for the detection and treatment of cancer; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the treatment of cancer and oncological conditions; none of the foregoing for use in connection with patient self-management, pain management or substance misuse;The color(s) white, green and blue is/are claimed as a feature of the mark.;design of personalized adoptive cell therapies for others; none of the foregoing for use in connection with patient self-management, pain management or substance misuse;
PACT PHARMA PACT Pharma, Inc. 2 Corporate Drive South San Francisco CA 94080 Bio-manufacturing for others, namely, manufacturing of adoptive cell and personalized adoptive cell therapies; none of the foregoing for use in connection with patient self-management, pain management or substance misuse;PHARMA;
PACT PHARMA PACT Pharma, Inc. 2 Corporate Drive South San Francisco CA 94080 Bio-manufacturing for others, namely, manufacturing of adoptive cell and personalized adoptive cell therapies; none of the foregoing for use in connection with patient self-management, pain management or substance misuse;The mark consists of the word PACT in the color white with a line split between the letter T on a background that is an irregular circular shape and 3 colors. The first color closest to the word PACT is dark blue, the center color is light blue, and the last color is green. The word PHARMA is to the right of the irregular circular shape in the color white and lowercase characters. The irregular circular shape is shaped like a T-cell. The black background is not part of the mark.;pharmaceutical preparations and substances for the treatment of genetic diseases, immunological diseases and cancer; personalized cell therapies for medical use for the treatment of cancer; biological preparations for medical purposes, namely, in the field of personalized cell therapies for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; pharmaceuticals, namely, immunotherapies for the treatment of cancer; oncological preparations, namely, pharmaceutical products for the detection and treatment of cancer; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the treatment of cancer and oncological conditions; none of the foregoing for use in connection with patient self-management, pain management or substance misuse;The color(s) White, dark blue, light blue and green is/are claimed as a feature of the mark.;PHARMA;design of personalized adoptive cell therapies for others; none of the foregoing for use in connection with patient self-management, pain management or substance misuse;
VITRUVIAN GENERAL ELECTRIC COMPANY (Trademarks: 801-4) 901 Main Avenue Norwalk CT 06851 Bio manufacturing for others, namely, manufacturing of cell and gene therapies using biological organisms in the manufacturing process; contract manufacturing in the fields of cell and gene therapies;Downloadable computer software for ordering, scheduling, tracking, production, manufacturing, business intelligence, and delivery of custom cell and gene therapies; downloadable cloud-computing software for ordering, tracking, scheduling, production, manufacturing, business intelligence, and delivery of custom cell and gene therapies;Operating an online-marketplace featuring cell and gene therapy treatments and services; business consulting services, namely, data analytics for others in the fields of cell and gene therapies;Assays for research purposes; assays and reagents for use in genetic research;Software as a service (SAAS) services, namely, hosting software for use by others for ordering, tracking, scheduling, production, manufacturing, business intelligence, and delivery of custom cell and gene therapies; Providing a website featuring non-downloadable software for ordering, tracking, scheduling, production, manufacturing, business intelligence, and delivery of custom cell and gene therapies; Custom design and development of chemical reagents and biochemical assays;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Provided are a system and method for automatically tracking a lot being moved between first and second manufacturing lines during semiconductor manufacturing. In one example, the method includes assigning a first state to the lot to indicate the lot's presence in the first manufacturing line. A trigger event indicating that the lot has been moved to the second manufacturing line may be identified, and a second state may be determined for the lot to reflect the lot's presence in the second manufacturing line. The second state may then be assigned to the lot.